|
|
|||
|
|||
|
|
|||
|
namenda drug information |
|||
|
|
|||
|
|||
 
|
|||
|
|
|||
|
namenda drug information Generic Name: memantine HCl Date of Approval: Manufacturer: Treatment for: The U.S namenda drug information. Food and Drug Administration (FDA) has approved Namenda (memantineHCl) for the treatment of moderate to severe Alzheimer's disease namenda drug information. Namenda isthe first NMDA receptor antagonist to be approved for Alzheimer's disease andis also the only therapy approved for the treatment of moderate to severe Alzheimer'sdisease. Namenda's FDA approval is based on the Agency's review of safety and efficacydata from two U.S namenda drug information. placebo-controlled Phase III clinical trials and an earliertrial conducted among nursing home patients in Europe namenda drug information. Phase III data includeda 28-week monotherapy study of 252 patients published earlier this year in theNew England Journal of Medicine and a six-month, 401-patient study of Namendawhen used together with an ongoing regimen of the commonly used Alzheimer'sagent, donepezil namenda drug information. In trials, patients treated with Namenda scored higher onmeasures of cognition, daily function, and/or global performance namenda drug information. This developmentprogram for memantine was a joint effort between Forest and its licensor, MerzPharmaceuticals, who obtained centralized approval for memantine in the EuropeanUnion in 2002 namenda drug information. Merz Pharmaceuticals is a specialty pharmaceutical company dedicatedto research and development in the fields of neurology and psychiatry. In clinical trials, Namenda has been safe and well tolerated namenda drug information. The most commonadverse events observed in clinical trials are dizziness, headache, constipation,and confusion namenda drug information. Once available in pharmacies, Namenda will be administered orallyat a recommended dose of 10 mg BID following a four-week titration. Alzheimer's is a progressive disease of the brain and it is the most commontype of dementia namenda drug information. The term dementia is used to describe the progressive lossof cognitive, intellectual, or functional abilities namenda drug information. Published reports projectthat by 2010 more than 5.1 million people in the United States will have Alzheimer'sdisease namenda drug information. Currently, all Alzheimer's medications approved in the United Statesbelong to a class of agents called acetylcholinesterase inhibitors, which areindicated for patients with mild to moderate symptoms of the disease namenda drug information. Namendais the only approved therapy in the United States for moderate to severe Alzheimer'sdisease.
Namenda (memantine HCl) is the first of a new class of medications for Alzheimer'sdisease with a mechanism of action distinct from currently available drugs namenda drug information. Namenda is a low to moderate affinity NMDA (N-methyl-D- aspartate) receptorantagonist namenda drug information. It is thought that overexcitation of NMDA receptors by the neurotransmitterglutamate may play a role in Alzheimer's disease since glutamate plays an integralrole in the neural pathways associated with learning and memory namenda drug information. The excitotoxicityproduced by abnormal levels of glutamate is thought to be responsible for neuronalcell dysfunction and the eventual cell death observed in Alzheimer's disease namenda drug information. Namenda is thought to selectively block the excitotoxic effects associated withabnormal transmission of glutamate, while allowing for the physiological transmissionassociated with normal cell functioning. |
|||
 
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
| nnamenda drug information naamenda drug information nammenda drug information nameenda drug information namennda drug information namendda drug information namendaa drug information namenda drug information namenda ddrug information namenda drrug information namenda druug information namenda drugg information namenda drug information namenda drug iinformation namenda drug innformation namenda drug infformation namenda drug infoormation namenda drug inforrmation namenda drug informmation namenda drug informaation namenda drug informattion namenda drug informatiion namenda drug informatioon namenda drug informationn amenda drug information nmenda drug information naenda drug information namnda drug information nameda drug information namena drug information namend drug information namendadrug information namenda rug information namenda dug information namenda drg information namenda dru information namenda druginformation namenda drug nformation namenda drug iformation namenda drug inormation namenda drug infrmation namenda drug infomation namenda drug inforation namenda drug informtion namenda drug informaion namenda drug informaton namenda drug informatin namenda drug informatio n amenda drug information na menda drug information nam enda drug information name nda drug information namen da drug information namend a drug information namenda drug information namenda drug information namenda d rug information namenda dr ug information namenda dru g information namenda drug information namenda drug information namenda drug i nformation namenda drug in formation namenda drug inf ormation namenda drug info rmation namenda drug infor mation namenda drug inform ation namenda drug informa tion namenda drug informat ion namenda drug informati on namenda drug informatio n namenda drug information anmenda drug information nmaenda drug information naemnda drug information namneda drug information namedna drug information namenad drug information namend adrug information namendad rug information namenda rdug information namenda durg information namenda drgu information namenda dru ginformation namenda drugi nformation namenda drug niformation namenda drug ifnormation namenda drug inofrmation namenda drug infromation namenda drug infomration namenda drug inforamtion namenda drug informtaion namenda drug informaiton namenda drug informatoin namenda drug informatino anamenda drug information thenamenda drug information namenda drug information | |||
|
|
|||
|
|
|||
|
|
|||
|
Copyright 2005 D-S LTD. |
